RESEARCH-USE BIOSIMILAR ANTIBODY
Motavizumab
Monoclonal antibody · IgG1
Motavizumab (MEDI-524) is an anti-human RSV (respiratory syncytial virus) monoclonal antibody. Motavizumab can be used in respiratory syncytial virus infection in high-risk infants research.
TARGETRSV gpF
YMonoclonal antibody
CATALOGSC-BS-363
CATALOG NUMBERSC-BS-363
MOLECULAR WEIGHTApprox. 145.32 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Motavizumab (MEDI-524) is an anti-human RSV (respiratory syncytial virus) monoclonal antibody. Motavizumab can be used in respiratory syncytial virus infection in high-risk infants research.
Motavizumab is a recombinant research-use antibody directed against RSV gpF.